ENDOTOXEMIA AND SPECIFIC ANTIBODY BEHAVIOR AGAINST DIFFERENT ENDOTOXINS FOLLOWING MULTIPLE INJURIES

被引:34
作者
HIKI, N
BERGER, D
BUTTENSCHOEN, K
BOELKE, E
SEIDELMANN, M
STRECKER, W
KINZL, L
BEGER, HG
机构
[1] UNIV ULM,DEPT GEN SURG,D-89075 ULM,GERMANY
[2] UNIV ULM,DEPT TRAUMATOL,D-89075 ULM,GERMANY
[3] UNIV TOKYO,FAC MED,DEPT SURG 3,TOKYO 113,JAPAN
关键词
ENDOTOXIN; LIPOPOLYSACCHARIDE; LIPID A; TRAUMA; MULTIPLE INJURY; SPECIFIC ANTIBODY; ANTIENDOTOXIN ANTIBODY;
D O I
10.1097/00005373-199505000-00020
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The aim of this study was to establish the incidence of endotoxemia and the influence of endotoxin on specific antibody response after multiple injury. Blood samples were collected from 39 patients (median Injury Severity Score: 20.5) at 0-3 and 6-12 hours, and 1, 3, 5, and 10 days after admission. The endotoxin plasma levels were high at the first time point (mean = 0.421 endotoxin units/mL) and decreased in the later course. Total immunoglobulin levels of IgM, IgG, or IgA were low and increased throughout the observation period. Specific antibodies of the IgM class against two lipid A and four lipopolysaccharide preparations increased transiently but significantly on day 3 and/or day 5. No changes of specific antibody content against endotoxin or lipid A was seen in the IgG or IgA class. The specific antibody content of the different classes against alpha-hemolysin of Staphylococcus aureus did not differ during 10 days after trauma. The specific antibodies of the IgM class reacted with ail lipid A and LPS lipopolysaccharide preparations demonstrating cross-reactivity. These results suggest that endotoxin may be a specific stimulator of IgM antiendotoxin antibody secretion following trauma.
引用
收藏
页码:794 / 801
页数:8
相关论文
共 38 条
[21]   ABBREVIATED INJURY SCALE AND INJURY SEVERITY SCORE - A SCORING CHART [J].
GREENSPAN, L ;
MCLELLAN, BA ;
GREIG, H .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1985, 25 (01) :60-64
[22]   SELECTIVE TRIGGERING OF B-CELL SUBPOPULATIONS BY MITOGENS [J].
GRONOWICZ, E ;
COUTINHO, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1974, 4 (11) :771-776
[23]  
IZUI S, 1982, J EXP MED, V153, P324
[24]  
KEARNEY JF, 1975, J IMMUNOL, V115, P671
[25]   ANTIBODY-RESPONSES TO LIPID-A, CORE, AND O-SUGARS OF THE PSEUDOMONAS-AERUGINOSA LIPOPOLYSACCHARIDE IN CHRONICALLY INFECTED CYSTIC-FIBROSIS PATIENTS [J].
KRONBORG, G ;
FOMSGAARD, A ;
GALANOS, C ;
FREUDENBERG, MA ;
HOIBY, N .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (07) :1848-1855
[26]  
LEVITT D, 1981, CLIN IMMUNOL IMMUNOP, V118, P309
[27]   LIPID-A ANTIBODY DETERMINATIONS USING ELISA ON PATIENTS AT A CHILDRENS HOSPITAL - A PRELIMINARY-REPORT [J].
MARGET, W ;
WEISS, M ;
RUHLAND, B .
INFECTION, 1983, 11 (02) :84-86
[28]   IMMUNIZATION WITH ROUGH MUTANTS OF SALMONELLA-MINNESOTA - PROTECTIVE ACTIVITY OF IGM AND IGG ANTIBODY TO THE R595 (RE CHEMOTYPE) MUTANT [J].
MCCABE, WR ;
DEMARIA, A ;
BERBERICH, H ;
JOHNS, MA .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (02) :291-300
[29]  
MILLER SE, 1982, SURG CLIN N AM, V62, P167
[30]  
MOELLER G, 1973, Journal of Infectious Diseases, V128, pS52